je.st
news
Gilead beats Street 2Q forecasts on surge in sales, profit
2015-07-29 00:40:17| Biotech - Topix.net
Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences' second-quarter profit by 23 percent as total revenue for the biotech drugmaker jumped 26 percent and it raised its 2015 sales forecast for the second time. Gilead Sciences Inc., based in Foster City, California, said Tuesday that its net income was $4.49 billion, or $2.92 per share.
Tags: sales
street
profit
beats
Category:Biotechnology and Pharmaceuticals